Navigation Links
Western Growers Asks for Congressional AG Committee Hearings Regarding Salmonella Outbreak and Investigations
Date:6/28/2008

IRVINE, Calif., June 28 /PRNewswire-USNewswire/ -- Western Growers is urging the House Committee on Agriculture to hold hearings as soon as possible on the salmonella outbreak that has been associated with fresh, red round, roma and plum tomatoes.

FDA and CDC have been unable to definitively determine the source or the cause of this outbreak and while these issues remain a "mystery," tomato growers across the nation are suffering irreparable harm.

"Congress must investigate this matter and determine ways to avoid this in the future and make the innocent tomato growers, packers and shippers whole," said Tom Nassif, president and CEO of Western Growers."

"FDA's comments to the media earlier today do not leave us confident that a progressive narrowing of the investigation through a thorough trace back process is occurring. It is very possible that we may never know if tomatoes are the source or, if they are, where they were grown or processed or how they were contaminated.

"Our industry has taken dramatic steps to develop the strongest practices possible to prevent contamination in the field and throughout the supply chain. We have done this in close collaboration with public health authorities at the local and federal level. Now it is time to look at how FDA 'intervenes' in the event of an outbreak and how they 'communicate' with the public and industry to ensure that public health is protected without the irreparable destruction of agricultural economies.

"The collateral damage inflicted on thousands of innocent producers in this country by FDA blanket 'advisories,' such as with spinach and tomatoes cannot go unchallenged.

"We look forward to a positive response from the House Committee on Agriculture and to working with them to balance the important goals of protecting public health and agricultural economies," said Nassif.

Western Growers is an agricultural trade association whose members from Arizona and Cali
'/>"/>

SOURCE Western Growers
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
2. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
3. Evanston Northwestern Healthcare Wins Award For Patient Safety
4. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
5. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
6. UT Southwestern scientist receives NIH Directors New Innovator Award
7. UT Southwestern investigating hypothermic technique in treating pediatric head injuries
8. 2 UT Southwestern researchers elected to National Academy of Sciences Institute of Medicine
9. UT Southwestern researcher named Howard Hughes Medical Institute investigator
10. Nursing Scholarships Offered by Western Governors University for Masters Degree Programs
11. Northwestern Memorial Hospital Completes Move Into Its New Prentice Womens Hospital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...emo deal with insomnia, study shows , , ...leep disorders affect more than three-quarters of ...arly three times higher than that of the general p...more common in younger patients and in those with ...ter Medical Center researchers, who assessed sleep...
(Date:11/23/2009)...ewswire/--Hazelden,theinternationallyrenownednonpr...ershipteamforitsnewrecoverycenterinNaples,Florida....nlateMarch2010,andwillinitiallyprovideaddictiontre...yandoutpatientservices. ,, MichaelDemask,Ph.D.,...Naples,withBrendaIliff,M.A.,L.A.D.C.,asclinicaldir...
(Date:11/23/2009)...e-USNewswire/-- The AmericanLegislativeExchangeCo...passociationofstatelegislators,congratulatesSouthC... constitutionalamendment toprotecttherightofindivi...nowbecomesthe24thstatewherelegislatorshaveintroduc...reedomofChoiceinHealthCareAct . ,, (Logo: http:...
(Date:11/23/2009)...ence Writings at Stevens Institute of Technology w...rt Wright, journalist and founder, Bloggingheads.t...the Babbio Center for Technology Management, Room ...the media., In his new book "The Evolution of Go...wned for his popular works on evolutionary psychol...
(Date:11/23/2009)...udent Jennifer Heys wants to make her message clea...munities about contraception. , Heys, research,...ear more children, was read by experts from all ov...tional Conference on Family Planning in Kampala, U...ic Health, spent six months interviewing 421 peopl...
Breaking Medicine News(10 mins):Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2
...20 /PRNewswire-FirstCall/ - Hard to Treat Diseases...ce that the first batch of Influenca Vaccine (MEVA...so attend the tender of 2.5 million doses of influ...ne in Chile. The ISP (Instituto De Salud Publica d...
...0 Matrex Exhibits announces Bruce Bennett has rec... as Senior Account Executive. Bennett comes to Mat...focus on the medical, pharmaceutical, and healthca... offer," Bennett says. "Being able to guarantee ou...
...usive Relationships , , SEYMOUR, Tenn., March 20 ...ed by their significant others, many people wonder...ms to have it all. The situation becomes even more...n who will endure physical abuse of all kinds beca...
... rigorous environmental cleaning intervention can ...Staphylococcus aureus (MRSA) and other multidrug-...ts (ICUs), according to a new study presented toda...reduced the spread of MRSA to patients exposed to ...
... In 2005, the Scandinavian Prostate Cancer Group S...y improved prostate cancer survival compared with ...llow-up. At the 24th Annual EAU Congress in Stockh...dominantly included men whose prostate cancer was ...
... James S. Gordon, M.D., the distinguished psychi...for Mind-Body Medicine (CMBM), has just returned f...timony from people and institutions who were targe...ed, and their difficulty accepting Israel,s role i...
Other Medicine News:Health News:HARD TO TREAT DISEASES (HTDS) Influenca Vaccine (MEVAC-FLU) Enters Chilean Market 2Health News:What's Love Got to Do With It? 2Health News:What's Love Got to Do With It? 3Health News:Environmental Cleaning Intervention Reduces Transmission of Multidrug-Resistant Organisms in ICUs 2Health News:SPCG-4 trial: Update on watchful waiting versus radical prostatectomy 2Health News:New Hope & Resilience After Destruction and Killings in Gaza, Israel 2Health News:New Hope & Resilience After Destruction and Killings in Gaza, Israel 3Health News:New Hope & Resilience After Destruction and Killings in Gaza, Israel 4
(Date:11/23/2009)...3/PRNewswire-FirstCall/-- CumberlandPharmaceutical...esultsfromastudyevaluatingthesafetyandefficacyofCa...talizedburnpatients. ,, Statisticalsignificance...urnpatientsoverthefirst24hoursoftreatment.Thestudy...eburnscoveringmorethan10percenttotalbodysurfaceare...
(Date:11/23/2009)...3/PRNewswire-FirstCall/--WoundManagementTechnologi...iderofspecialtymedicalproducts,announcedthatithasf...ensivemanagementbusinessupdatetoillustratethedevel...esincreased33.5%to$102,926vs.Q32008salesof$77,084....3,327,892vs.Q32008shareholderequityof$(321,257) ,...
(Date:11/23/2009)...swire-FirstCall/--CordBloodAmerica,Inc.(OTCBulleti...tioncompany( http://www.cordblood-america.com )foc...iologicalinsurancepolicy,tofamiliesnationwideandin...nterviewwithCEOandco-founderMatthewSchisslerisnowa...p.tv/file/2875811 . ,, Intheinterview,Mr.Schiss...
Breaking Medicine Technology:Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India 14487 1SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India 14487 2Verathon Introduces the GlideScope 28R 29 Cobalt Advanced Video Laryngoscope 28AVL 29 3B New Digital Technology Facilitates Quick Intubations 5517 1Verathon Introduces the GlideScope 28R 29 Cobalt Advanced Video Laryngoscope 28AVL 29 3B New Digital Technology Facilitates Quick Intubations 5517 2American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 1American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 2American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 3American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 4
...bitor being developed for the ...ed a compelling 2.5% reduction in HbA1c in refract... -- ARI-2243 is a first-in-class "soft drug" conf...ectivity, -- Nonclinical toxicology evaluation sh... index, BOSTON, March 11 Arisaph ...
...vately held,biopharmaceutical company focused on t...oxygen transport agents, today announced that an,i... recommended the,continuation of both Phase III cl...roduct, Hemospan(R), under current protocols., Th... the blinded data,from the first two-thirds of the...
Other Medicine Technology:FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 2FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 3FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 4FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 5Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review 2
Buffered Wright-Giemsa Stain
Giemsa Stain
Albumin (BCP)
Albumin Reagent Set
Medicine Products: